Comment on Chandler et al. 23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type Streptococcus pneumoniae. Microorganisms 2022, 10, 560
Abstract
:Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Chandler, T.; Furmanek, S.; Carrico, R.; Balcom, D.; Arnold, F.; Ramirez, J. 23-valent pneumococcal polysaccharide vaccination does not prevent community-acquired pneumonia hospitalizations due to vaccine-type Streptococcus pneumoniae. Microorganisms 2022, 10, 560. [Google Scholar] [CrossRef] [PubMed]
- Hammitt, L.L.; Bulkow, L.R.; Singleton, R.J.; Nuorti, J.P.; Hummel, K.B.; Miernyk, K.M.; Zanis, C.; Whaley, M.; Romero-Steiner, S.; Butler, J.C.; et al. Repeat revaccination with 23-valent pneumococcal polysaccharide vaccine among adults aged 55-74 years living in Alaska: No evidence of hyporesponsiveness. Vaccine 2011, 29, 2287–2295. [Google Scholar] [CrossRef] [PubMed]
- Musher, D.M.; Manoff, S.B.; McFetridge, R.D.; Liss, C.L.; Marchese, R.D.; Raab, J.; Rueda, A.M.; Walker, M.L.; Hoover, P.A. Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults. Hum. Vaccin. 2011, 7, 919–928. [Google Scholar] [CrossRef] [PubMed]
- Tomczyk, S.; Bennett, N.M.; Stoecker, C.; Gierke, R.; Moore, M.R.; Whitney, C.G.; Hadler, S.; Pilishvili, T.; Centers for Disease Control and Prevention. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged >/=65 years: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly. Rep. 2014, 63, 822–825. [Google Scholar] [PubMed]
- McLaughlin, J.M.; Jiang, Q.; Isturiz, R.E.; Sings, H.L.; Swerdlow, D.L.; Gessner, B.D.; Carrico, R.M.; Peyrani, P.; Wiemken, T.L.; Mattingly, W.A.; et al. Effectiveness of 13-valent pneumococcal conjugate vaccine against hospitalization for community-acquired pneumonia in older US adults: A test-negative design. Clin. Infect. Dis. 2018, 67, 1498–1506. [Google Scholar] [CrossRef] [PubMed]
- Groom, H.; Hopkins, D.P.; Pabst, L.J.; Murphy Morgan, J.; Patel, M.; Calonge, N.; Coyle, R.; Dombkowski, K.; Groom, A.V.; Kurilo, M.B.; et al. Immunization information systems to increase vaccination rates: A community guide systematic review. J Public Health Manag. Pract. 2015, 21, 227–248. [Google Scholar] [CrossRef] [PubMed]
- Kolasa, M.S.; Cherry, J.E.; Chilkatowsky, A.P.; Reyes, D.P.; Lutz, J.P. Practice-based electronic billing systems and their impact on immunization registries. J. Public Health Manag. Pract. 2005, 11, 493–499. [Google Scholar] [CrossRef] [PubMed]
- Koepke, R.; Petit, A.B.; Ayele, R.A.; Eickhoff, J.C.; Schauer, S.L.; Verdon, M.J.; Hopfensperger, D.J.; Conway, J.H.; Davis, J.P. Completeness and accuracy of the wisconsin immunization registry: An evaluation coinciding with the beginning of meaningful use. J. Public Health Manag. Pract. 2015, 21, 273–281. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Vandenbroucke, J.P.; Pearce, N. Test-negative designs: Differences and commonalities with other case-control studies with “other patient” controls. Epidemiology 2019, 30, 838–844. [Google Scholar] [CrossRef] [PubMed]
- Sullivan, S.G.; Tchetgen Tchetgen, E.J.; Cowling, B.J. Theoretical basis of the test-negative study design for assessment of influenza vaccine effectiveness. Am. J. Epidemiol. 2016, 184, 345–353. [Google Scholar] [CrossRef] [PubMed]
- Dean, N.E.; Hogan, J.W.; Schnitzer, M.E. COVID-19 vaccine effectiveness and the test-negative design. N. Engl. J. Med. 2021, 385, 1431–1433. [Google Scholar] [CrossRef] [PubMed]
- Thompson, M.G.; Stenehjem, E.; Grannis, S.; Ball, S.W.; Naleway, A.L.; Ong, T.C.; DeSilva, M.B.; Natarajan, K.; Bozio, C.H.; Lewis, N.; et al. Effectiveness of COVID-19 vaccines in ambulatory and inpatient care settings. N. Engl. J. Med. 2021, 385, 1355–1371. [Google Scholar] [CrossRef] [PubMed]
- Mandell, L.A. Community-acquired pneumonia: An overview. Postgrad Med. 2015, 127, 607–615. [Google Scholar] [CrossRef] [PubMed]
Base Case | 1.5% of Controls Considered Vaccinated | 3% of Controls Considered Vaccinated | ||||
---|---|---|---|---|---|---|
VT CAP Case | Non-VT CAP Control | VT CAP Case | Non-VT CAP Control | VT CAP Case | Non-VT CAP Control | |
PPSV23 vaccinated | 48 | 560 | 48 | 610 | 48 | 660 |
Not vaccinated | 288 | 2790 | 288 | 2740 | 288 | 2690 |
OR | 0.83 (48 × 2790)/(288 × 560) | 0.75 (48 × 2740)/(288 × 610) | 0.68 (48 × 2690)/(288 × 660) | |||
VE | 17% (1−0.83) × 100% | 25% (1−0.75) × 100% | 32% (1−0.68) × 100% |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Cossrow, N.; Joshi, R.; Klinker, K.; Buchwald, U.K. Comment on Chandler et al. 23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type Streptococcus pneumoniae. Microorganisms 2022, 10, 560. Microorganisms 2022, 10, 1987. https://doi.org/10.3390/microorganisms10101987
Cossrow N, Joshi R, Klinker K, Buchwald UK. Comment on Chandler et al. 23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type Streptococcus pneumoniae. Microorganisms 2022, 10, 560. Microorganisms. 2022; 10(10):1987. https://doi.org/10.3390/microorganisms10101987
Chicago/Turabian StyleCossrow, Nicole, Rennie Joshi, Kenneth Klinker, and Ulrike K. Buchwald. 2022. "Comment on Chandler et al. 23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type Streptococcus pneumoniae. Microorganisms 2022, 10, 560" Microorganisms 10, no. 10: 1987. https://doi.org/10.3390/microorganisms10101987